Based on network pharmacological analysis, the core targets of AS-TMP combination for anti-ischemic stroke are TIMP-1, VEGFA, MMP9, etc., which are mainly related to apoptosis, cell proliferation, and vascular smooth muscle cell proliferation, focusing on the VEGF signaling pathway. The gene discussed is TIMP1; the disease is ischemic stroke.